Cargando…
Analysis of lncRNA UCA1‐related downstream pathways and molecules of cisplatin resistance in lung adenocarcinoma
BACKGROUND: To analyze the lncRNA UCA1‐related downstream pathways and molecules of cisplatin resistance in lung adenocarcinoma. METHODS: We constructed overexpression and siRNA vectors targeting UCA1 and TXNIP and then used next‐generation sequencing to compare the UCA1 overexpression and negative...
Autores principales: | Zhou, Huixin, Shen, Qiang, Fu, Jiali, Jiang, Feng, Wang, Liangxing, Wang, Yumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439354/ https://www.ncbi.nlm.nih.gov/pubmed/32249461 http://dx.doi.org/10.1002/jcla.23312 |
Ejemplares similares
-
Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma
por: Fu, Jiali, et al.
Publicado: (2021) -
Super enhancer‐LncRNA SENCR promoted cisplatin resistance and growth of NSCLC through upregulating FLI1
por: Shen, Qiang, et al.
Publicado: (2022) -
Low expression of PRKCDBP promoted cisplatin resistance in lung adenocarcinoma by DNMT1 and TNF-α
por: Fu, Jiali, et al.
Publicado: (2020) -
The prognostic value and mechanisms of lncRNA UCA1 in human cancer
por: Yao, Fei, et al.
Publicado: (2019) -
lncRNA LOC100132354 promotes angiogenesis through VEGFA/VEGFR2 signaling pathway in lung adenocarcinoma
por: Wang, Yumin, et al.
Publicado: (2018)